- Brand Name- Nublexa
- Innovator Brand Name- Stivarga
- API- Regorafenib
- Packaging- 28 Tablets
- Strength- 40 mg
- Manufacturer Name- Bayer
South Delhi Pharma can facilitate the supply of “Nublexa (Regorafenib” to all locations in the world and in India after fulfilling the legal requirement (if applicable). Nublexa (Regorafenib is a prescription drug and should be used under proper medical guidance and advice. The order will be confirmed only after the receipt of valid prescription of doctor and import permit if applicable.
Get In Touch
Get in touch with us at South Delhi Pharma (SDP), and one of our team will be on hand to help with any queries you may have.
The SDM is open
Monday to Friday.
Business hours: 09:30 A.M to 18:30 P.M.
M:+91-9891296838 / P:+91-11- 26532129
What Nublexa is?
Regorafenib is a multi-kinase inhibitor, indicated for the treatment of:
- Metastatic Colorectal Cancer
- Advanced Hepatocellular Carcinoma
- Also, Advanced Gastoinstenstial Stromal Tumors
What Regorafenib is?
Regorafenib, sold under the brand name Stivarga among others, is an oral multi-kinase inhibitor developed by Bayer which targets angiogenic, stromal and oncogenic receptor tyrosine kinase (RTK). Regorafenib shows anti-angiogenic activity due to its dual targeted VEGFR2-TIE2 tyrosine kinase inhibition. Since 2009 it was studied as a potential treatment option in multiple tumor types.